The treatment of testicular cancer includes unilateral orchiectomy and chemotherapy and is curative for most patients. However, observational studies revealed an association with depression, anxiety and cognitive impairment. It is unclear whether these side effects are caused by chemotherapy, hemicastration or the disease itself. The aim of our study was to analyse the behavioural effects of hemicastration and chemotherapy in adult male mice. The animals were randomly divided into four groups-control, chemotherapy, hemicastration and hemicastration with chemotherapy. After chemotherapy that included three cycles of bleomycin, etoposide, cisplatin mice underwent a battery of behavioural tests. To assess the long-term effects animals were tested also 3 months after the end of treatment. Chemotherapy led to lower locomotor-and exploratory activity, higher anxiety-like behaviour and worse spatial memory immediately after treatment. These behavioural effects were not present three months later. Hemicastration had no effect on most of the observed outcomes. In conclusion, adverse behavioural effects induced by chemotherapy in mice are transient and disappear later in life. Further studies are needed to elucidate the mechanisms responsible for the observed effects. Testicular cancer primarily affects young men at reproductive age 1. Nowadays, testicular cancer is highly curable due to advances in treatment for testicular cancer 2,3. Primary surgery (orchiectomy) followed by three to four cycles of multiagent chemotherapy (bleomycin, etoposide and cisplatin) has been considered as the standard first-line treatment of metastatic testicular cancer 4. Despite high efficacy of this type of testicular cancer treatment, its adverse effects on quality of life were also reported. Besides deleterious effect of chemotherapy on reproductive function of men 5,6 , adverse behavioural effects including higher levels of anxiety and depression 7,8 , fatigue and cognitive impairment 9-11 were also indicated. Clinical studies suggest that the mentioned adverse effects of chemotherapy are long-lasting-higher anxiety and depression are present even 11 years following the chemotherapy treatment 12,13. Amidi et al. 9 have observed cognitive impairment (impaired working memory, visual learning and memory, executive functioning, verbal learning and memory, processing speed) in testicular cancer patients 2-7 years following treatment. Chovanec et al. 14 have reported a decrease in overall cognitive function score (sum of four subscales: perceived cognitive impairment and cognitive abilities, quality of life affected by cognitive impairment, cognitive impairment perceived by others) in patients 5-32 years following chemotherapy and radiotherapy treatment 15. On the contrary, some studies have brought different results 16,17 indicating the need to study the effects in controlled experimental conditions. Animal studies have shown gonadotoxic effects of chemotherapy for testicular cancer on the morphology and function of male rat reproductive system...